AVAH vs INDV: fair value comparison
Aveanna Healthcare Holdings Inc. and Indivior Pharmaceuticals, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, AVAH currently sits closer to the top of our discount ranking. AVAH carries the stronger quality grade.
| AVAH | INDV | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $9.61 | $37.37 |
| 12-month range | $6.29–$9.61 | $23.46–$40.25 |
| Sector rank | #28 of 113 Healthcare | #29 of 113 Healthcare |
| Quality grade | D | F |
| Leverage | High | Low |
| Margin trend | — | Stable |
| Revenue growth | — | Modest |
| RSI zone | Overbought | Oversold |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: AVAH fair value analysis · INDV fair value analysis